Joseph Biederman Selected Research

Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)

1/2022	Identifying Pediatric Mood Disorders From Transdiagnostic Polygenic Risk Scores: A Study of Children and Adolescents.
1/2022	Review: Adult Outcome as Seen Through Controlled Prospective Follow-up Studies of Children With Attention-Deficit/Hyperactivity Disorder Followed Into Adulthood.
1/2022	Nicotine and the developing brain: Insights from preclinical models.
1/2022	Repetitive Mild Traumatic Brain Injury in an Awake, Unanesthetized Mouse Model of Perinatal Nicotine Exposure Produces Transient Novelty-Seeking and Depression-Like Behaviors.
1/2022	Using a Digital Meditation Application to Mitigate Anxiety and Sleep Problems in Children with ADHD.
10/2021	Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets.
5/2021	How Frequent Is Switching From an Initial Stimulant Family to the Alternative One in the Clinical Setting?: A Pilot Study of 49 Consecutively Referred Medication-Naive Adults With Attention-Deficit/Hyperactivity Disorder.
1/2021	Frontal Cortical Monoamine Release, Attention, and Working Memory in a Perinatal Nicotine Exposure Mouse Model Following Kappa Opioid Receptor Antagonism.
1/2021	Further Evidence that Subsyndromal Manifestations of Depression in Childhood Predict the Subsequent Development of Major Depression: A Replication Study in a 10 Year Longitudinally Assessed Sample.
1/2021	L-Threonic Acid Magnesium Salt Supplementation in ADHD: An Open-Label Pilot Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph Biederman Research Topics

Disease

180	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 01/2002
28	Bipolar Disorder (Manic Depressive Psychosis) 12/2021 - 10/2002
18	Mania (Manias) 01/2022 - 07/2003
14	Substance-Related Disorders (Drug Abuse) 02/2012 - 01/2002
8	Mental Disorders (Mental Disorder) 11/2017 - 01/2003
8	Anxiety Disorders (Anxiety Disorder) 06/2013 - 02/2006
7	Body Weight (Weight, Body) 06/2013 - 01/2003
6	Autism Spectrum Disorder 01/2022 - 01/2012
5	Headache (Headaches) 12/2012 - 06/2005
5	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2007 - 06/2005
4	Mood Disorders (Mood Disorder) 01/2022 - 10/2005
4	Weight Gain 11/2017 - 10/2007
4	Alcoholism (Alcohol Abuse) 09/2012 - 01/2002
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 03/2010 - 01/2003
4	Oppositional Defiant Disorder 01/2007 - 01/2003
3	Brain Concussion (Cerebral Concussion) 01/2022 - 01/2021
3	Antisocial Personality Disorder (Antisocial Personality) 10/2018 - 02/2006
3	Epilepsy (Aura) 07/2014 - 01/2004
3	Psychotic Disorders (Schizoaffective Disorder) 06/2013 - 02/2006
3	Nausea 12/2012 - 02/2006
3	Hypertension (High Blood Pressure) 05/2006 - 01/2002
3	Tics (Tic) 02/2006 - 01/2002
2	Neurodevelopmental Disorders 01/2022 - 01/2021
2	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 06/2013
2	Fatigue 01/2020 - 12/2012
2	Conduct Disorder (Conduct Disorders) 10/2018 - 08/2009
2	Autistic Disorder (Autism) 06/2016 - 08/2013
2	Panic Disorder (Panic Attack) 12/2014 - 06/2005
2	Seizures (Absence Seizure) 07/2014 - 11/2006
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2014 - 03/2006
2	Depressive Disorder (Melancholia) 12/2009 - 10/2005
2	Tobacco Use Disorder (Nicotine Dependence) 05/2008 - 02/2006
2	Abdominal Pain (Pain, Abdominal) 03/2007 - 02/2006
2	Vomiting 03/2007 - 02/2006
2	Tic Disorders (Tic Disorder) 01/2003 - 07/2002

Drug/Important Bio-Agent (IBA)

47	Methylphenidate (Ritalin)FDA LinkGeneric 05/2021 - 03/2002
28	Pharmaceutical PreparationsIBA 01/2017 - 04/2002
26	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2013 - 01/2002
24	Amphetamine (Amfetamine)FDA LinkGeneric 05/2021 - 03/2002
14	SaltsIBA 11/2007 - 06/2003
12	Nicotine FDA Link 01/2022 - 04/2002
12	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 07/2013 - 08/2002
8	Antipsychotic Agents (Antipsychotics)IBA 11/2017 - 10/2005
8	SLI381IBA 03/2006 - 08/2002
7	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2002
6	Lisdexamfetamine Dimesylate FDA Link 12/2019 - 03/2007
6	Antidepressive Agents (Antidepressants)IBA 01/2019 - 01/2002
6	Glutamic Acid (Glutamate)FDA Link 11/2014 - 02/2006
6	Biological ProductsIBA 10/2008 - 02/2005
6	Modafinil (Provigil)FDA Link 03/2008 - 12/2005
6	Risperidone (Risperdal Consta)FDA LinkGeneric 02/2008 - 01/2004
6	Bupropion (Wellbutrin)FDA LinkGeneric 07/2007 - 01/2002
5	SmokeIBA 05/2017 - 04/2002
5	Delayed-Action PreparationsIBA 05/2011 - 06/2003
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 07/2012
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 01/2002
4	Olanzapine (Zyprexa)FDA Link 03/2010 - 10/2005
4	Antihypertensive Agents (Antihypertensives)IBA 05/2006 - 01/2002
4	TabletsIBA 05/2006 - 12/2005
4	AdderallIBA 06/2003 - 06/2002
3	Indicators and Reagents (Reagents)IBA 12/2021 - 10/2005
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2017 - 05/2007
3	Memantine (Namenda)FDA Link 01/2017 - 05/2013
3	Inositol (Myoinositol)IBA 11/2015 - 02/2006
3	3' Untranslated Regions (3' UTR)IBA 10/2013 - 06/2008
3	Protons (Proton)IBA 01/2012 - 02/2006
3	Glutamine (L-Glutamine)FDA Link 01/2012 - 02/2006
3	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 03/2006 - 08/2005
2	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 01/2022 - 05/2006
2	Antimanic AgentsIBA 01/2022 - 08/2011
2	4-aminospiroperidolIBA 10/2018 - 12/2007
2	Naltrexone (ReVia)FDA LinkGeneric 03/2018 - 01/2018
2	Narcotic Antagonists (Opioid Antagonists)IBA 03/2018 - 01/2018
2	Illicit Drugs (Recreational Drugs)IBA 01/2017 - 02/2006
2	Anticonvulsants (Antiepileptic Drugs)IBA 07/2014 - 08/2011
2	Therapeutic UsesIBA 07/2012 - 08/2002
2	N 30IBA 08/2010 - 10/2005
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2009 - 09/2007
2	Guanfacine (Tenex)FDA LinkGeneric 02/2009 - 01/2008
2	Aripiprazole (Abilify)FDA Link 09/2007 - 02/2005
2	P-2 (P 2)IBA 09/2007 - 10/2005
2	Donepezil (Aricept)FDA LinkGeneric 02/2006 - 12/2005
2	Desipramine (Pertofrane)FDA LinkGeneric 02/2005 - 07/2002
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2003 - 01/2002
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 07/2002 - 01/2002
2	Opioid Analgesics (Opioids)IBA 04/2002 - 01/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Pemetrexed (MTA)FDA Link 01/2022
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	threonic acid (threonate)IBA 01/2021
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2021
1	AutoantibodiesIBA 01/2019
1	Controlled SubstancesIBA 01/2019

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
12	Therapeutics 05/2013 - 07/2002
4	Aftercare (After-Treatment) 01/2019 - 10/2005
1	Low-Level Light Therapy (LLLT) 01/2022
1	Meditation 01/2022
1	Combined Modality Therapy 01/2022
1	Treatment Delay 01/2021